Barts Revascularisation Registry

Summary

Despite the year-on-year decrease, coronary artery disease (CAD) still remains one of the leading cause of mortality worldwide. With advances in technology and our understanding of cardiac disease, we can now treat CAD using minimally invasive interventional techniques. This has revolutionised treatment for and improved the lives of many patients with CAD. Although trials have assessed various therapeutic strategies in various populations, real-world evidence of intervention and medical treatment among patients with CAD is increasingly recognised as an important part of providing safety and efficacy data and improving the care we provide. This data will add to that literature by assessing the characteristics and outcomes of patients with CAD. It will also identify and characterise predictors of outcomes, improve risk stratification and diagnostic evaluation.

Eligibility

Inclusion Criteria:

* Informed consent will not be sought for, as patients are automatically included onto a database that we will use for research purposes.
* No children will be included in this study.
* Vulnerable adults or those unable to give consent will be included in the study as well if they are referred to the Interventional Cardiology team.
* Both male and female patients ≥16 years of age will be included
* All patients will have had an angiogram at BHC.
* Any patient who has undergone revascularisation.

Exclusion Criteria:

• Patients \<16 years will not be included in this study.

Conditions3

Browse More Trials